Raleigh-based Bryn Pharma brings on new CEO to help launch EpiPen alternative

Bryn Pharma names pharmaceutical industry veteran Sandy Loreaux as the new CEO, with hopes she has the commercialization experience to advance their Epi-Pen alternative.